NEWS and OPINIONS

MEGA-CRISPR tool gives a power boost to cancer-fighting cells

MEGA-CRISPR tool gives a power boost to cancer-fighting cells

By Sara Reardon - Nature - The CRISPR–Cas9 gene-editing system excels at altering and disrupting genes. But the changes it makes are permanent, which can be a big problem if the system goes awry. Now, a CRISPR-based system that targets a cell’s short-lived messenger...

read more
US biotech fundraising boom ends 2-year deal drought

US biotech fundraising boom ends 2-year deal drought

By Nicholas Megaw - Fianacial Times - Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom. Drug developers raised $6.2bn in equity capital markets in January, according to data from...

read more
FDA approves first cell therapy for solid tumors

FDA approves first cell therapy for solid tumors

by Megan Giboney - RegMedNet - The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes a population...

read more
Boosting health equity with lab-grown tissues

Boosting health equity with lab-grown tissues

By University of California Irvine - Popular Science recently chose Quinton Smith, UC Irvine assistant professor of chemical and biomolecular engineering, as one of its Brilliant 10 scientists “on the cusp of changing the world” for his research on growing tissue from...

read more